Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
Go back to Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 59.66 -4.3 (6.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.96 | 52 Week High | $0.52 | |||
| Open | $64.07 | 52 Week Low | $0.08 | |||
| Day High | $65.51 | P/E | N/A | |||
| Day Low | $57.50 | EPS | $-3.80 | |||
| Volume | 5,151,049 | |||||
